Seroprevalence of Dengue and Chikungunya Virus Antibodies, French Polynesia, 2014–2015

Maïté Aubry(Institut Louis Malardé), Anita Teissier(Institut Louis Malardé), Michael Huart(Santé Publique France), Sébastien Merceron(University of French Polynesia), Jessica Vanhomwegen(Institut Pasteur), Mihiau Mapotoeke(University of French Polynesia), Teheipuaura Mariteragi-Helle(Institut Louis Malardé), Claudine Roche(Institut Louis Malardé), Anne-Laure Vial(University of French Polynesia), Sylvianne Teururai(Institut Louis Malardé), Sébastien Sicard(Economic & Social Sciences, Health Systems & Medical Informatics), Sylvie Paulous(Institut Pasteur), Philippe Desprès(Écologie Marine Tropicale des Océans Pacifique et Indien), Jean‐Claude Manuguerra(Institut Pasteur), Henri‐Pierre Mallet(University of French Polynesia), Allison Imrie(The University of Western Australia), Didier Musso(Institut Louis Malardé), Xavier Deparis(Inserm), Van‐Mai Cao‐Lormeau(Institut Louis Malardé)
Emerging infectious diseases
January 29, 2018
Cited by 36Open Access
Full Text

Abstract

We investigated dengue and chikungunya virus antibody seroprevalence in French Polynesia during 2014-2015. Dengue virus seroprevalence was ≈60% among schoolchildren and >83% among the general population; chikungunya virus seroprevalence was <3% before and 76% after Zika virus emergence (2013). Dengue virus herd immunity may affect Zika virus infection and pathogenesis.


Related Papers

No related papers found

Powered by citation graph analysis